Madeleine Foster, Chief Pharmaceutical Officer’s Clinical at SPS, presents a summary of the resources published by SPS between 19th and 25th July.

To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.

Quick links to highlighted resources:

Key principles on avoiding ingredients in medicines

Spiritual, religious, cultural, and lifestyle factors can affect preferences for excipients and active ingredients in medicines. We cover key principles.

https://www.sps.nhs.uk/articles/key-principles-on-avoiding-ingredients-in-medicines/

Avoiding animal contents within medicines

Our guidance on supporting patients avoiding animal products, offers you informed, patient-centred decisions regarding animal containing or derived medicines.

https://www.sps.nhs.uk/articles/avoiding-animal-contents-within-medicines/

Benzylpenicillin for Group B Streptococcus for use in neonates

SPS PGD template for the intrapartum administration of benzylpenicillin for prevention of early-onset Group B Streptococcus (GBS) infection in neonates.

https://www.sps.nhs.uk/articles/benzylpenicillin-for-group-b-streptococcus-for-use-in-neonates/

Terbutaline injection for use in labour within maternity services

SPS PGD template for administering subcutaneous terbutaline sulfate for the reduction of contraction frequency in individuals in labour.

https://www.sps.nhs.uk/articles/terbutaline-injection-for-labour-within-maternity-services/

Combined oral hormonal contraceptive (COC) in reproductive health

SPS PGD template for the supply of a combined oral hormonal contraceptive for contraception, or for individuals requiring control of problematic bleeding.

https://www.sps.nhs.uk/articles/combined-oral-hormonal-contraceptive-coc-in-reproductive-health/

Progestogen only pill (POP) for contraception

SPS PGD template for the supply of a progestogen only pill (POP) for contraception.

https://www.sps.nhs.uk/articles/progestogen-only-pill-pop-for-contraception/

Preparing to use aflibercept 2mg biosimilar

Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.

https://www.sps.nhs.uk/articles/preparing-to-use-aflibercept-2mg-biosimilar/

Next events – forthcoming webinars and conferences

https://www.sps.nhs.uk/home/events/next-events/

Podcast description:

NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.